LataMed AI Corp. (OTC: LMED) announced that its mobile healthcare application has entered the final stage of development, with the company completing testing and optimization ahead of a planned launch on the Apple App Store and Google Play. The announcement signals a transition from development to public availability for the company's digital healthcare ecosystem, which aims to improve access to medical services across Latin America.
The application is expected to serve as the primary mobile access point to LataMed AI's platform, offering users a convenient interface to supported healthcare services and digital tools. Management anticipates submitting the app for distribution in the coming weeks, subject to platform review and technical requirements. Once live, the app will provide a scalable foundation for introducing additional functionality, including patient-facing tools, healthcare-provider interaction, and digital communications.
Dr. Kevin Rodan Levy, CEO of LataMed AI, emphasized the importance of mobile accessibility in the region, noting that smartphones are a primary means of accessing digital services for many individuals. "Our objective is to create a platform that is practical, accessible and capable of expanding as we continue introducing additional healthcare services and artificial intelligence-supported tools," he said.
The mobile app is part of LataMed AI's broader strategy to connect patients, healthcare professionals, pharmacies, insurers, and other stakeholders in an integrated digital health environment. The company is also developing AI-supported platforms, including CardioAI, PulmoAI, and NeuroAI, which are intended to assist healthcare professionals in evaluating cardiovascular, pulmonary, and neurological health information. These technologies remain in development and are subject to regulatory requirements and commercial implementation.
The announcement follows the company's ongoing efforts to build digital health infrastructure in Latin America, where access to traditional healthcare can be limited. By launching on both major mobile platforms, LataMed AI aims to provide a direct and accessible way for users to interact with its healthcare ecosystem. The company believes this move will support its long-term goal of creating a more connected healthcare experience.
For more information, visit latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
